Status:
TERMINATED
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
VA Boston Healthcare System
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
Detailed Description
Risperidone in low doses is compared with placebo in a 6-week randomized trial. Subjects also receive supportive counseling. Outcome measure include rating of behavior, mood, drug abuse, global functi...
Eligibility Criteria
Inclusion Criteria:
Cocaine abuse or dependence
Exclusion Criteria:
Dependence on other drugs. Major psychiatric illness
Key Trial Info
Start Date :
January 1 1996
Trial Type :
INTERVENTIONAL
End Date :
March 1 1996
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000310
Start Date
January 1 1996
End Date
March 1 1996
Last Update
January 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brown University School of Medicine
Providence, Rhode Island, United States, 2906